Revelation Biosciences, Inc. ( REVB) - Stock Earnings
REVB Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
REVB Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.5 million USD | — USD |
| 2026Q1 | -3.0 million USD | — USD |
| 2026Q2 | -3.3 million USD | — USD |
| 2026Q4 Est. | — | — |
REVB Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -120254 USD | — USD |
| 2024 | -15.0 million USD | — USD |
| 2025 | -8.9 million USD | — USD |
| 2026 Est. | — | — |
REVB
Price: $3.68
Earnings Per Share: 26.55 USD
P/E Ratio: 0.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 562000
Market Capitalization: 3.9 million